-
France threatens Shein ban if 'childlike' sex dolls reappear
-
International cricket returns to Faisalabad with Pakistan-South Africa ODIs
-
Afghan govt says quake kills 20, injures over 500
-
'We're all too rich,' says photo legend Martin Parr
-
Tanzania president inaugurated as opposition says hundreds dead
-
Shafali Verma: India's World Cup hero who disguised herself as boy
-
Most equity markets rise on lingering trader optimism
-
Asian markets rise on lingering trader optimism
-
Afghanistan quake kills 20, injures over 300: health ministry
-
India hails maiden women's World Cup cricket title as game-changer
-
As clock ticks down, Greece tries to clean up its act on waste
-
Local fabrics, fibres shine at eco-centred Lagos Fashion Week
-
Spalletti bidding to revive Juve and reputation ahead of Sporting visit in Champions League
-
Tanzania president to be inaugurated as opposition says hundreds dead
-
Bouanga brace as LAFC beats Austin 4-1 to advance in MLS Cup playoffs
-
'Golden age': Japan hails Yamamoto, Ohtani after Dodgers triumph
-
Thunder roll over Pelicans to remain NBA's lone unbeaten team
-
Hong Kong legislature now an 'echo chamber', four years after shake-up
-
Most Asian markets rise on lingering trader optimism
-
Andrew to lose his last military rank: defence minister
-
Trump's global tariffs to face challenge before Supreme Court
-
Barnstorming Bayern face acid test at reigning champions PSG
-
Alonso shaping new Real Madrid on Liverpool return
-
Half Yours favourite at Australia's 'race that stops a nation'
-
Tonga rugby league star has surgery after 'seizure' against NZ
-
Trent's return with Real Madrid reminds Liverpool of what they are missing
-
Tehran toy museum brings old childhood memories to life
-
Iran banking on Iraq vote to retain regional influence
-
Daughter of 'underground' pastor urges China for his release
-
Trump the Great? President steps up power moves
-
Fire ravages French monastery dubbed 'Notre-Dame of the Ardennes'
-
Bills outlast Chiefs while NFL-best Colts fall to Steelers
-
NBA champion Thunder roll over Pelicans to remain unbeaten
-
Eliud Kipchoge unveils plan to run 7 marathons on 7 continents
-
Milan deny Roma top spot in Serie A, Inter beat Verona
-
Lens back up to third in Ligue 1 as Lyon held at Brest
-
NFL-best Colts fall to Steelers, Packers lose to Carolina
-
'Regretting You' wins spooky slow N. American box office
-
'Just the beginning' as India lift first Women's World Cup
-
Will Still sacked by struggling Southampton
-
Malinin wins Skate Canada crown with stunning free skate
-
Barca beat Elche to recover from Clasico loss
-
Jamaica deaths at 28 as Caribbean reels from colossal hurricane
-
Verma and Sharma power India to first Women's World Cup triumph
-
Auger-Aliassime out of Metz Open despite not yet securing ATP Finals spot
-
Haaland fires Man City up to second in Premier League
-
Sinner says staying world number one 'not only in my hands'
-
Ready for it? Swifties swarm German museum to see Ophelia painting
-
Pope denounces violence in Sudan, renews call for ceasefire
-
Kipruto, Obiri seal Kenyan double at New York Marathon
Sacklers, Purdue to pay $7.4 bn over opioid crisis: NY state
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
The opioid addiction epidemic has caused more than 500,000 overdose deaths in the United States over two decades.
Thursday's settlement, which will see funds routed to communities and individuals affected by opioid, is the largest of several targeting the makers and sellers of the highly addictive drugs.
The $7.4 billion settlement was agreed "in principle with members of the Sackler family and their company Purdue Pharma for their instrumental role in creating the opioid crisis," New York Attorney General Letitia James's office said in a statement.
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid crisis.
O.Mousa--SF-PST